Can we rely only on ratios of cerebrospinal fluid biomarkers for AD biological diagnosis?-Reference-Cited by-同舟云学术

Can we rely only on ratios of cerebrospinal fluid biomarkers for AD biological diagnosis?

Published:2014-11-15 Issue:9 Volume:11 Page:1125-1126
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Lehmann Sylvain¹,Gabelle Audrey¹²,Paquet Claire³

Affiliation:

1. CHRU de Montpellier Université Montpellier I, IRMB, INSERM U1040, CCBHM, Laboratoire de Biochimie Protéomique Clinique Montpellier France

2. Centre Mémoire Ressources Recherche Languedoc‐Roussillon, CHRU de Montpellier, hôpital Gui de Chauliac Montpellier France

3. Centre Mémoire Ressources Recherche Paris Nord Ile de France and Histologie et Biologie du Vieillissement, Groupe Hospitalier Saint‐Louis, Lariboisière Fernand‐Widal APHP, INSERM U942, Université Paris Diderot Paris France

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2014.09.003

Reference10 articles.

1. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

2. The cerebrospinal fluid “Alzheimer profile”: Easily said, but what does it mean?

3. Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort

4. Impact of the 2008‐2012 French Alzheimer Plan on the use of cerebrospinal fluid biomarkers in research memory center: the PLM Study;Gabelle A;J Alzheimers Dis,2013

5. A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles;Lehmann S;Alzheimers Res Ther,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview;Alzheimer's & Dementia;2021-12-22

2. CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment;Frontiers in Aging Neuroscience;2021-08-26

3. Network-constrained technique to characterize pathology progression rate in Alzheimer’s disease;Brain Communications;2021

4. CSF cutoffs for MCI due to AD depend on APOEε4 carrier status;Neurobiology of Aging;2020-05

5. Mild Cognitive Impairment and Early Dementia;Research on Cognition Disorders;2020